Price
$3.65
Increased by +9.61%
Dollar volume (20D)
205.66 K
ADR%
8.93
Earnings report date
Jul 30, 2024
Shares float
5.43 M
Shares short
31.67 K [0.58%]
Shares outstanding
6.99 M
Market cap
24.31 M
Beta
0.12
Price/earnings
N/A
20D range
2.26 3.69
50D range
2.26 3.69
200D range
2.26 13.49

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders.

The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia.

Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 1, 24 -1.13
Increased by +13.74%
-1.20
Increased by +5.83%
Feb 22, 24 -1.39
Decreased by -10.32%
-0.88
Decreased by -57.95%
Nov 7, 23 -1.03
Increased by +20.16%
-0.77
Decreased by -33.77%
Aug 1, 23 -1.12
Increased by +31.29%
-0.44
Decreased by -154.55%
May 15, 23 -1.31
Increased by +28.80%
-1.63
Increased by +19.63%
Mar 8, 23 -1.26
Increased by +68.50%
-0.92
Decreased by -36.96%
Nov 9, 22 -1.29
Increased by +26.70%
-1.32
Increased by +2.27%
Aug 9, 22 -1.63
Increased by +18.50%
-1.65
Increased by +1.21%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 N/A
Decreased by N/A%
-8.57 T
Decreased by -238.07 M%
- -
Dec 31, 23 0.00
Decreased by N/A%
-9.02 M
Decreased by -7.64%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-7.82 M
Increased by +9.00%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-6.19 M
Increased by +28.36%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-3.60 M
Increased by +63.12%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-8.38 M
Increased by +60.66%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by -100.00%
-8.59 M
Increased by +6.64%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by -100.00%
-8.64 M
Increased by +18.37%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY